Molecular Tumor Board

There's nothing like cancer, many survivors say, to remind you that nothing is guaranteed. Good or bad. Renee Garber got an unexpected "bonus year."

“I had always considered myself one of the healthiest people I knew ...”

Duke Cancer Institute has given stage 4 cancer survivor Milos Bogetic precious extra time with his wife and growing young son.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.